Companhia Brasileira de Distribuicao (NYSE:CBD) marked $3.34 per share on Wednesday, up from a previous closing price of $3.32. While Companhia Brasileira de Distribuicao has overperformed by 0.60%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CBD fell by -17.44%, with highs and lows ranging from $5.50 to $2.73, whereas the simple moving average fell by -15.84% in the last 200 days.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
On July 25, 2022, JP Morgan Downgraded Companhia Brasileira de Distribuicao (NYSE: CBD) to Neutral. A report published by BofA Securities on May 04, 2022, Upgraded its rating to ‘Buy’ for CBD. BofA/Merrill June 26, 2019d its ‘Buy’ rating to ‘Neutral’ for CBD, as published in its report on June 26, 2019. Credit Suisse also rated the stock as ‘Outperform’.
Analysis of Companhia Brasileira de Distribuicao (CBD)
CBD currently pays a dividend of $0.07 per share, which means investors will get a return regardless of the company’s performance over the next few months. Further, the quarter-over-quarter increase in sales is 8.90%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Companhia Brasileira de Distribuicao’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 12.20% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.60, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 950.58K can be a very valuable indicator of volatility for CBD stock. On a monthly basis, the volatility of the stock is set at 4.90%, whereas on a weekly basis, it is put at 4.56%, with a loss of -6.96% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.50, showing growth from the present price of $3.34, which can serve as yet another indication of whether CBD is worth investing in or should be passed over.
How Do You Analyze Companhia Brasileira de Distribuicao Shares?
The Brazil based company Companhia Brasileira de Distribuicao (CBD) is one of the biggest names in Department Stores. When comparing Companhia Brasileira de Distribuicao shares with other companies under Consumer Cyclical, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 15.25, there is a growth in quarterly earnings of -213.80%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 57.40%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 5.70% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in CBD shares?
The recent increase in stakes in CBD appears to be a result of several institutional investors and hedge funds increasing their positions. Morgan Stanley Uruguay Ltda.’s position in CBD has increased by 102.43% in the first quarter. The company now owns 2,434,180 shares of the stock, with a value of $10.25 million, following the purchase of 1,231,701 additional shares during the last quarter. Banco BTG Pactual SA made another increased to its shares in CBD during the first quarter, upping its stake by 9,361.80%. During the last quarter, the company picked up 2,266,678 additional shares for a total stake of worth $9.64 million, bringing number of shares owned by the company to 2,290,890.
During the first quarter, SPX Equities Gestão de Recursos L added a 214,042 position in CBD. UBS Switzerland AG sold an additional 9800.0 shares in the last quarter, decreasing its holdings by -0.99%, now holding 0.98 million shares worth $4.13 million. At the end of the first quarter, The Vanguard Group, Inc. decreased its CBD holdings by -13.19% and now holds 0.84 million CBD shares valued at $3.54 million with the lessened -0.13 million shares during the period. CBD shares are owned by institutional investors to the tune of 5.70% at present.